We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest News
C-Path and Ventana Medical Systems to Collaborate on Developing Standardized Evaluation for Companion Diagnostic Tests and Targeted Cancer Therapies
News

C-Path and Ventana Medical Systems to Collaborate on Developing Standardized Evaluation for Companion Diagnostic Tests and Targeted Cancer Therapies

C-Path has received a $2.1 million grant from Science Foundation Arizona to fund a collaboration project with the US FDA and the National Cancer Institute.
Enigma Diagnostics Announces a European Commission Award of EUR3 Million
News

Enigma Diagnostics Announces a European Commission Award of EUR3 Million

The award will fund the development of a point of care platform for the rapid diagnosis of influenza infections.
GE and Lilly Collaborates to Co-Develop Molecular In-Vitro Diagnostics for Cancer Treatments
News

GE and Lilly Collaborates to Co-Develop Molecular In-Vitro Diagnostics for Cancer Treatments

The collaboration is focused on developing diagnostic tools to predict patients’ response to targeted therapies.
New Nordic EMBL Partnership for Molecular Medicine
News

New Nordic EMBL Partnership for Molecular Medicine

EMBL has partnered with Universities of Finland, Oslo and Umea to explore molecularly and genetically based treatments.
Cellumen Establishes Collaboration in Breast Cancer Patient Stratification
News

Cellumen Establishes Collaboration in Breast Cancer Patient Stratification

The goal of collaboration is to create a breast cancer patient profile test to improve diagnosis and treatment for individualized medicine.
Agendia Joins the Personalized Medicine Coalition
News

Agendia Joins the Personalized Medicine Coalition

The company focuses on the development and commercialization of diagnostic tests using tumor gene expression profiling.
DxS K-RAS Mutation Detection Kit Used To Assess Tumour Mutation Status Prior to Treatment with Amgen’s Vectibix™
News

DxS K-RAS Mutation Detection Kit Used To Assess Tumour Mutation Status Prior to Treatment with Amgen’s Vectibix™

Amgen has selected Kit to analyse patient samples from the pivotal“408” study examining Vectibix versus best supportive care in patients with metastatic colorectal cancer.
Molecular Sensing to Commercialize New Biosensor Technology Exclusively Licensed from Vanderbilt University
News

Molecular Sensing to Commercialize New Biosensor Technology Exclusively Licensed from Vanderbilt University

MSI plans to produce biosensor products for research, diagnostic, biodefense and pharmacogenomic applications.
Moffitt Selects Microsoft's Azyxxi to Help Drive Personalized Cancer Treatment
News

Moffitt Selects Microsoft's Azyxxi to Help Drive Personalized Cancer Treatment

Software to save years in research that aligns patients and treatments.
Oxford Genome Sciences Announces New Therapeutic Antibody Deal with Medarex
News

Oxford Genome Sciences Announces New Therapeutic Antibody Deal with Medarex

New agreement to drive the development of OGeS’ own pipeline of antibodies in cancer.
Advertisement